Company intelligence / Profile preview

Niagen Bioscience

Los Angeles, California, United Statesniagenbioscience.com ↗
Ownership
Public · NAGE
Employees
~119
Development stage
Other
01

Overview

Niagen Bioscience’s flagship product Niagen® has been the subject of over 35 human clinical studies and more than 400 published scientific studies. Clinical results show that supplementation with nicotinamide riboside chloride safely and effectively increases NAD+ levels in humans. Tru Niagen®, the company’s consumer product line featuring this ingredient, has sold over eight million bottles globally. The company also recently launched pharmaceutical-grade injectable/IV forms for clinical use.

Therapeutic areas
NeurologyMetabolic DisordersOther
Modalities
Small molecule (nicotinamide riboside chloride)Dietary supplement ingredient (nutraceutical)Pharmaceutical ingredient (for IV/injectable use)
Industry
Biotech
02

Drug pipeline

3 assets

pTeroPure

3

2 more assets in the full pipeline.

03

Partnerships

Collaborations with major academic institutions including National Institutes of Health, Biotechnology and Biological Sciences Research Council, Northwestern University Feinberg School of Medicine

Beyond the preview

Go deeper on Niagen Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niagen Bioscience.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call